- Alberta Innovates
- Biofibres is big in Alberta
Biofibres is big in Alberta.
Alberta is taking the lead in the burgeoning biomaterials industry. The biofibres program through Alberta Innovates Tech Future is the largest of its kind in Canada, offering solutions "from seed to final product". Alberta Innovates is a key partner in the Alberta Biomaterials Development Centre, one of the largest, most comprehensive biofibre development programs in the world. This centre provides a single window to access all the biomaterial expertise Alberta has to offer.
- $1 billion, a 30–year legacy and health and medical innovation
Alberta Innovates Health Solutions has a 30-year legacy of supporting top-quality, world-renowned research, formerly under the name Alberta Heritage Foundation for Medical Research (AHFMR). During that time, we have invested more than $1 billion in health and medical research.
- Another first. Sleep apnea discovery
Dr. John Remmers, a global leader in sleep physiology and sleep medicine, was the first to demonstrate that sleep apnea, a condition in which a person stops breathing periodically during sleep, is due to an anatomical narrowing of the pharynx. Dr. Remmers produced CPAP and the SnortSat sleep recorder.
- Wheat straw offers shelter and withstands earthquakes
Alberta Innovates - Technology Futures developed technology that uses wheat straw to solve a pressing human need for shelter, profoundly improves the living conditions of millions of people, reduces greenhouse gas emissions and protects the environment on a large scale.
- Where to find Canada’s National Institute of Nanotechnology? Alberta, naturally
Alberta is home to some of Canada's most significant nanotechnology assets, including the National Institute for Nanotechnolgy. Alberta is also a destination for the world when it comes to nanotechnology research, product development and commercialization. Alberta Innovates - Technology Futures oversees all of nano activities in Alberta, making it easier for local and international stakeholders to access Alberta's growing web of nanotechnology resources.
- New technology equates to a 60 per cent reduction in CO2 emissions
- New oil sands technology eliminates need for tailings ponds
- 35 years managing investments in energy research and developement
- The Food Processing Development Centre at Leduc is Canada’s largest of its kind and the only one with a major focus on applied research
- Dr. Westaway is a world–leading prion researcher
- Located in Alberta, Canada’s largest poultry research and value–added centre has built an international reputation as a top collaborative R&D centre and learning hub over the last 25 years
- SAGD government and industry collaboration could double viability of oil sands reserves
Alberta-wide team unveils ambitious plan to combat chronic diseases in an effort to make medical treatment more efficient and cost effective. Research targets non-communicable, chronic diseases like high blood pressure, diabetes, kidney and vascular disease because they are currently the largest growing diseases
Alberta Innovates has captured attention globally. When we have the opportunity to speak with researchers and innovators outside of Alberta, they wonder how we have put the system together and achieved the alignment that we have achieved.
Dr. Cy Frank is one of the leading figures in the field of bone and joint injury in the world and attributes his presence in Alberta to Alberta Innovates Health Solutions.
Ron Dyck, Assistant Deputy Minister of Research and Innovation Division of Advanced Education and Technology, discusses the mandate of Alberta Innovates. Alberta Innovates brings together research and industry together in a new way.
These are DNA samples that will be loaded to agarose gel in small disposable vials.
The hepatoma cell line is unique because it allows the hepatitis C virus to be isolate while it infects the cells in the tissue culture hood. Therefore the virus can be studied due to its safe environment.
Agarose gel is used for running DNA samples. It separates DNA fragments based in size by subjecting them to an electric current. Agarose allows the analysis of unique DNA fragments that have previously digested with specific enzymes or specific gene products that have been generated by DNA amplification.
The hepatoma cells in the culture dish allow for the HCV infection and can then be used for future studies.